Oppenheimer Holdings Inc Stock News

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to present at the Oppenheimer 32nd Annual Virtual Healthcare Conference on Wednesday, March 16, 2022 at 2:00 p.m. Eastern Time. John Martins, Group President Delivery, and William J. Burns, Executive Vice President & Chief Financial Officer, will be attending the conference. An audio webcast and presentation for this conference will be available on the Compan

Oppenheimer is sticking up for Digital Turbine stock (APPS -12.3%) - caught in a downdraft coming from Google''s initiative to cut back advertising tracking on its Android mobile…

Amgen had its price target increased by Oppenheimer from $272.00 to $285.00 in a report released on Wednesday morning, Price Targets.com reports. They currently have an

Oppenheimer Holdings (NYSE:OPY) had declared $0.15/share quarterly dividend, in line with previous.Payable Feb. 25; for shareholders of record Feb. 11; ex-div Feb.

4Q22 earnings impacted by lower incentive income on alternative investments. Capital market division has record results.

Jason Helfstein, Oppenheimer managing director of internet equity research, joins ''Power Lunch'' to discuss Meta''s quarterly earnings results and how investors should play the stock.

Oppenheimer has upgraded shares of NovoCure from perform to outperform citing the company current valuation and growth from the release of next-generation arrays mid

Lodging firm Sonder Holdings Inc. (SOND) rose 6.5% after receiving a new outperform rating at Oppenheimer after going public following a de-spacing last month. "We see SOND''s broad

Following more than 18% rise on Friday in reaction to its announcement on the FDA approval of Omnipod 5, Insulet <> is extending gains after Oppenheimer upgraded the stock

Oppenheimer Holdings press release (OPY): Q4 GAAP EPS of $4.61.Revenue of $365.11M (-13.7% Y/Y).

Citi, Goldman, JPMorgan Urge Investors To BTFD Is the worst behind us? According to strategists from Goldman Sachs, Citi, JPMorgan, and BofA (selectively), it is time to buy-the-f**king-dip. The market is experiencing a correction within an ongoing bull market cycle according to Goldman''s Peter Oppenheimer Any further significant weakness at the index level should be seen as a buying opportunity, in our view, The key thing for equities from here is how much any of this shift upward in interest rate expectations and indeed in financial conditions will hit growth, Goldmans Oppenheimer said in an interview with Bloomberg Television. Thats going to be key to determine where equity markets stabilize. Specifically, Goldman notes that their Risk Appetite Indicator (GSRAII) has fallen back, suggesting we are getting closer to levels that have typically been a good entry point for longer-term investors. Goldman warns that the biggest risk is that high valuations will continue to unwind should real rates rise much further, but they note the crucial determinant is what is happening to growth .

Oppenheimer lowers its price target on Outperform-rated Vector Group (VGR) to $13.50 to account for the completed spin-off of Douglas Elliman on December 30. Read more.

The market did not seem very pleased with Plug Powers (PLUG) latest business update. Shares took the down escalator after the company reiterated its 2022 revenue g

Record earnings in 9M 2021.